Literature DB >> 25282551

Structure-activity relationships of non-opioid [des-Arg(7)]-dynorphin A analogues for bradykinin receptors.

Yeon Sun Lee1, David Rankin2, Sara M Hall3, Cyf Ramos-Colon3, Jose Juan Ortiz3, Robert Kupp3, Frank Porreca2, Josephine Lai2, Victor J Hruby4.   

Abstract

In our earlier studies, bradykinin receptors (BRs) were identified as a potential target for the neuroexcitatory effects of dynorphin A (Dyn A) in the central nervous system (CNS), and [des-Arg(7)]-Dyn A-(4-11) (6) was discovered as a lead ligand to modulate Dyn A-(2-13) induced neuroexcitatory effects in the CNS as an antagonist. In an effort to gain insights into key structural features of the Dyn A for the BRs, we pursued further structure-activity relationships (SAR) study on the [des-Arg(7)]-Dyn A analogs and confirmed that all of the [des-Arg(7)]-Dyn A analogues showed good binding affinities at the BRs.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bradykinin receptors; Chronic pain; Non-opioid dynorphin A; Structure–activity relationship; pH sensitivity

Mesh:

Substances:

Year:  2014        PMID: 25282551      PMCID: PMC4250343          DOI: 10.1016/j.bmcl.2014.09.033

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  14 in total

Review 1.  Mechanisms of opioid-induced pain and antinociceptive tolerance: descending facilitation and spinal dynorphin.

Authors:  T W Vanderah; M H Ossipov; J Lai; T P Malan; F Porreca
Journal:  Pain       Date:  2001-05       Impact factor: 6.961

2.  Opioid, cheating on its receptors, exacerbates pain.

Authors:  Christophe Altier; Gerald W Zamponi
Journal:  Nat Neurosci       Date:  2006-12       Impact factor: 24.884

3.  Dynorphin A activates bradykinin receptors to maintain neuropathic pain.

Authors:  Josephine Lai; Miaw-Chyi Luo; Qingmin Chen; Shouwu Ma; Luis R Gardell; Michael H Ossipov; Frank Porreca
Journal:  Nat Neurosci       Date:  2006-11-19       Impact factor: 24.884

Review 4.  New paradigms and tools in drug design for pain and addiction.

Authors:  Victor J Hruby; Frank Porreca; Henry I Yamamura; Gordon Tollin; Richard S Agnes; Yeon Sun Lee; Minying Cai; Isabel Alves; Scott Cowell; Eva Varga; Peg Davis; Zdzislaw Salamon; William Roeske; Todd Vanderah; Josephine Lai
Journal:  AAPS J       Date:  2006-07-14       Impact factor: 4.009

Review 5.  Is paradoxical pain induced by sustained opioid exposure an underlying mechanism of opioid antinociceptive tolerance?

Authors:  Tamara King; Michael H Ossipov; Todd W Vanderah; Frank Porreca; Josephine Lai
Journal:  Neurosignals       Date:  2005

Review 6.  Pharmacology of bradykinin and related kinins.

Authors:  D Regoli; J Barabé
Journal:  Pharmacol Rev       Date:  1980-03       Impact factor: 25.468

7.  Neuropathic plasticity in the opioid and non-opioid actions of dynorphin A fragments and their interactions with bradykinin B2 receptors on neuronal activity in the rat spinal cord.

Authors:  Kirsty Bannister; Yeon Sun Lee; Leonor Goncalves; Frank Porreca; Josephine Lai; Anthony H Dickenson
Journal:  Neuropharmacology       Date:  2014-06-14       Impact factor: 5.250

Review 8.  Neuropathic pain: the paradox of dynorphin.

Authors:  J Lai; M H Ossipov; T W Vanderah; T P Malan; F Porreca
Journal:  Mol Interv       Date:  2001-08

9.  Nonopioid actions of intrathecal dynorphin evoke spinal excitatory amino acid and prostaglandin E2 release mediated by cyclooxygenase-1 and -2.

Authors:  Lee Koetzner; Xiao-Ying Hua; Josephine Lai; Frank Porreca; Tony Yaksh
Journal:  J Neurosci       Date:  2004-02-11       Impact factor: 6.167

10.  Discovery of amphipathic dynorphin A analogues to inhibit the neuroexcitatory effects of dynorphin A through bradykinin receptors in the spinal cord.

Authors:  Yeon Sun Lee; Dhanasekaran Muthu; Sara M Hall; Cyf Ramos-Colon; David Rankin; Jackie Hu; Alexander J Sandweiss; Milena De Felice; Jennifer Yanhua Xie; Todd W Vanderah; Frank Porreca; Josephine Lai; Victor J Hruby
Journal:  J Am Chem Soc       Date:  2014-04-29       Impact factor: 15.419

View more
  7 in total

Review 1.  Dynorphin A analogs for the treatment of chronic neuropathic pain.

Authors:  Sara M Hall; Yeon Sun Lee; Victor J Hruby
Journal:  Future Med Chem       Date:  2016-01-29       Impact factor: 3.808

2.  Design, synthesis and biological evaluation of multifunctional ligands targeting opioid and bradykinin 2 receptors.

Authors:  Srinivas Deekonda; David Rankin; Peg Davis; Josephine Lai; Frank Porreca; Victor J Hruby
Journal:  Bioorg Med Chem Lett       Date:  2015-08-14       Impact factor: 2.823

3.  Modification of amphipathic non-opioid dynorphin A analogues for rat brain bradykinin receptors.

Authors:  Yeon Sun Lee; Sara M Hall; Cyf Ramos-Colon; Michael Remesic; Lindsay LeBaron; Ann Nguyen; David Rankin; Frank Porreca; Josephine Lai; Victor J Hruby
Journal:  Bioorg Med Chem Lett       Date:  2014-11-15       Impact factor: 2.823

4.  Cyclic non-opioid dynorphin A analogues for the bradykinin receptors.

Authors:  Yeon Sun Lee; Michael Remesic; Cyf Ramos-Colon; Sara M Hall; Alexander Kuzmin; David Rankin; Frank Porreca; Josephine Lai; Victor J Hruby
Journal:  Bioorg Med Chem Lett       Date:  2016-10-06       Impact factor: 2.823

5.  Blockade of non-opioid excitatory effects of spinal dynorphin A at bradykinin receptors.

Authors:  Yeon Sun Lee; Sara M Hall; Cyf Ramos-Colon; Michael Remesic; David Rankin; Todd W Vanderah; Frank Porreca; Josephine Lai; Victor J Hruby
Journal:  Receptors Clin Investig       Date:  2015

6.  Various modifications of the amphipathic dynorphin A pharmacophore for rat brain bradykinin receptors.

Authors:  Yeon Sun Lee; Robert Kupp; Michael V Remesic; Cyf Ramos-Colon; Sara M Hall; Christopher Chan; David Rankin; Josephine Lai; Frank Porreca; Victor J Hruby
Journal:  Chem Biol Drug Des       Date:  2016-06-06       Impact factor: 2.817

7.  Discovery of Stable Non-opioid Dynorphin A Analogues Interacting at the Bradykinin Receptors for the Treatment of Neuropathic Pain.

Authors:  Sara M Hall; Lindsay LeBaron; Cyf Ramos-Colon; Chaoling Qu; Jennifer Yanhua Xie; Frank Porreca; Josephine Lai; Yeon Sun Lee; Victor J Hruby
Journal:  ACS Chem Neurosci       Date:  2016-09-27       Impact factor: 4.418

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.